Related Experiment Videos
Accelerated versus classical hepatitis B virus vaccination programs in healthcare workers accelerated vs. classical
Mustafa Oktay Tarhan1, All Ihsan Aker, Oguz Resat Sipahi
1Department of Internal Medicine Division of Oncology, Ataturk Training and Research Hospital, Izmir, Turkey.
Background:
The aim of this study was to compare the efficacy of a standard hepatitis B virus vaccination program (day 0-30-60) with an accelerated vaccination program (day 0-10-21) in healthy healthcare workers.
Material/Methods:
Participants were randomly assigned to a classical (group 1, days 0, 30, and 60) or an accelerated vaccination program (group 2, days 0, 10, and 21). The vaccine used was 20 pg recombinant hepatitis B vaccine (recombinant hepatitis B vaccine derived from yeast cells, Engerix B, Smith Cline Beachum). HBV markers were re-examined for the emergence of anti-HBsAg and also to detect the development of a possible acute HBV infection one, two, and three months after the last dose of vaccine. Anti-HBsAg titers >10 mIU/l were accepted as protective.
Results:
The seroprotection rates were similar one, two, and three months after the last dose of vaccine in both groups. Anti-HBsAg titers in group 1 were higher than in group 2 two and three months after the last dose of vaccination (p<0.05).
Conclusions:
Our data indicate that the accelerated HBV vaccination program was as effective as the classical vaccination program.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Vaccinations
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Vaccines